Google is looming large over the advertising technology world, the ACCC says in a new report highlighting growing concerns the global tech giant’s “unrivalled” ability to preference its own technology could affect competition.
A lawsuit seeking to increase D&O insurance for sandalwood producer Quintis in the wake of a class action settlement has fallen short of the $40 million in additional coverage sought, but a Federal Court decision may see a further $11.25 million go to group members.
Multinational pharmaceutical company Dr Reddy’s has launched a lawsuit against a Melbourne biotechnology company’s directors as well as venture capital firm OneVentures, alleging they sold it dodgy lice treatment which was forecasted to make over US$100 million.
A Melbourne law firm and barrister will soon face trial over allegations of breach of fiduciary duty brought by a former client who lost a lawsuit over a $24.5 million property joint venture.
The wealthy owners of a Melbourne shoe manufacturer are taking a unit of property developer JD Group to trial this week, alleging “artist impressions” of a nearly $10 million off-the-plan high rise inner city apartment were misleading and deceptive.
While a Federal Court judge recently promised to advance a long-running criminal cartel case against several investment banks and individuals over a $2.5 billion ANZ share placement, a separate judge will soon hear a privilege dispute over documents from whistleblower JPMorgan that promises to further delay the case.
A former high ranking executive from National Australia Bank has been sentenced to eight years in prison for receiving bribes in the form of inflated invoices to the tune of around $5.5 million.
Venture capitalist Dr Elaine Stead has been awarded $280,000 in her defamation case against the Nine-owned Australian Financial Review after the Federal Court found she suffered hurt and damage to her reputation through a “targeted campaign of offensive mockery” about her role in collapsed investment firm Blue Sky Alternative Investments.
An account director for Oracle is suing the tech company alleging he was fired for making complaints about one of his superiors who allegedly told him he had “zero EQ” and “an innate ability to annoy and anger people”.
Drug giant Merck Sharp & Dohme has brought a cross appeal in its long-running intellectual property dispute with Pfizer’s Wyeth over the top selling Prevnar 13 pneumococcal vaccine.